Search - tctmd.com

Displaying 241 - 260 of 774

Sort: Relevancy | Date

Presentation NY Valves 2024

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Presenter: Philipp Lurz

June 06, 2024

Presentation NY Valves 2024

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

Presenter: David A. Wood

June 06, 2024

Presentation NY Valves 2024

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Presenter: Michael Joseph Rinaldi

June 06, 2024

Presentation NY Valves 2024

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

Presenter: Shephal K. Doshi

June 06, 2024

Presentation NY Valves 2024

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

Presenter: JoAnn Lindenfeld

June 06, 2024

Presentation NY Valves 2024

TricValve: Technology and Clinical Update

Presenter: Rishi Puri

June 06, 2024

Presentation NY Valves 2024

Transcatheter Management of Sinus of Valsalva to Left Ventricular Fistula Resulting in Cardiogenic Shock

Presenter: Matthew Lawlor

June 06, 2024

Presentation NY Valves 2024

Residual Tricuspid Regurgitation After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the Eurotr Registry

Presenter: Lukas Stolz

June 06, 2024

Presentation NY Valves 2024

Is Robotic Aortic Valve Replacement (RAVR) an Alternative to TAVR? Technique and Multicenter Experience

Presenter: Arnar Geirsson

June 06, 2024

Presentation NY Valves 2024

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

Presenter: Antonio Mangieri

June 06, 2024

Presentation NY Valves 2024

Debate Con

Presenter: Amr E. Abbas

June 06, 2024

Presentation NY Valves 2024

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

Presenter: Anna Sannino

June 06, 2024

Presentation NY Valves 2024

The 2024 'Toolbox' for Leaflet Modification in TAVR

Presenter: Jaffar M. Khan

June 06, 2024

Presentation NY Valves 2024

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?

Presenter: Rodrigo D. Estevez-Loureiro

June 06, 2024

Presentation NY Valves 2024

Debate Pro

Presenter: Howard C. Herrmann

June 06, 2024

Presentation NY Valves 2024

Current Status of LAAO in the United States: Device Utilization, Indications, and Clinical Outcomes

Presenter: Matthew J. Price

June 06, 2024

Presentation NY Valves 2024

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Presenter: Scott M. Chadderdon

June 06, 2024

Presentation NY Valves 2024

Valve Thrombosis and Antithrombotic Therapy After Surgical and Transcatheter Mitral Valve Replacement: A Systematic Review and Meta-Analysis

Presenter: Mark Zorman

June 06, 2024

Presentation NY Valves 2024

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

Presenter: Jonathan Michel

June 06, 2024

Advertisement

Heterotopic TTVR in Patients With Severe TR: First-in-Human Experience With the Trillium Device

Debate Pro: Invasive Assessment is Mandatory to Confirm Bioprosthetic Valve Dysfunction /Failure

CON: M-TEER for ALL Phenotypes – Symptomatic Improvement Is Enough

Expanding Indications for LAAO to Front Line Therapy for Stroke Reduction in AF: Clinical Trial Updates

PRO: M-TEER for COAPT-Eligible Patients Only – The Evidence is Clear

TricValve: Technology and Clinical Update

Transcatheter Management of Sinus of Valsalva to Left Ventricular Fistula Resulting in Cardiogenic Shock

Residual Tricuspid Regurgitation After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the Eurotr Registry

Is Robotic Aortic Valve Replacement (RAVR) an Alternative to TAVR? Technique and Multicenter Experience

Is Leaflet Modification Sufficient to Prevent Coronary Obstruction - When to Consider Snorkel Stenting

Debate Con

The Heterogeneity of Functional MR: Phenotype Clusters and Implications for Management

The 2024 'Toolbox' for Leaflet Modification in TAVR

Management of Aortic Stenosis in Low-Risk Patients – Current Options and Controversies

Keynote Lecture: Heterotopic TTVR: Where Do We Draw the Line in Patient Indication?

Debate Pro

Current Status of LAAO in the United States: Device Utilization, Indications, and Clinical Outcomes

Case Presentation: Imaging in Asymptomatic AR – Diagnosis, Risk Assessment, and Follow-up

Valve Thrombosis and Antithrombotic Therapy After Surgical and Transcatheter Mitral Valve Replacement: A Systematic Review and Meta-Analysis

Ultima Ratio: Emergency TAVR for Acute Iatrogenic Aortic Regurgitation During Endovascular Aortic Stenting

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content